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Ankrd11 is a potential chromatin regulator implicated
in neural development and autism spectrum disorder
(ASD) with no known function in the brain. Here, we
show that knockdown of Ankrd11 in developing
murine or human cortical neural precursors caused
decreased proliferation, reduced neurogenesis,
and aberrant neuronal positioning. Similar cellular
phenotypes and aberrant ASD-like behaviors were
observed in Yoda mice carrying a point mutation
in the Ankrd11 HDAC-binding domain. Consistent
with a role for Ankrd11 in histone acetylation,
Ankrd11 was associated with chromatin and colocal-
ized with HDAC3, and expression and histone acety-
lation of Ankrd11 target genes were altered in Yoda
neural precursors. Moreover, the Ankrd11 knock-
down-mediated decrease in precursor proliferation
was rescued by inhibiting histone acetyltransferase
activity or expressing HDAC3. Thus, Ankrd11 is a
crucial chromatin regulator that controls histone
acetylation and gene expression during neural devel-
opment, thereby providing a likely explanation for its
association with cognitive dysfunction and ASD.
INTRODUCTION
We currently understand little about mechanisms that are
dysregulated in human neurodevelopmental disorders like
ASD. In ASD, many different genes are affected by sporadic
or rare-inherited DNA sequence mutations or copy-number
variations (Devlin and Scherer, 2012). Many of these areDeveinvolved in synapse function, but others, such as Ankyrin
repeat domain containing protein 11 (Ankrd11; Zhang et al.,
2004), are associated with transcription or chromatin regula-
tion, but have no known role in the brain (Pinto et al., 2014; Ios-
sifov et al., 2014). In humans, deletion or mutation of one allele
of the ANKRD11 gene causes cognitive dysfunction and ASD
(Marshall et al., 2008; Sirmaci et al., 2011; Lo-Castro et al.,
2013), and some individuals display corpus callosum hypopla-
sia and periventricular heterotopias (Willemsen et al., 2010).
Intriguingly, cell line studies indicate that Ankrd11 is a large
nuclear protein that regulates transcription, potentially by bind-
ing chromatin modifying enzymes like histone deacetylases
(HDACs) (Zhang et al., 2004, 2007a, 2007b; Li et al., 2008;
Neilsen et al., 2008).
Modification of chromatin structure by histone acetylation is
essential for nervous system development and function and
plays a particularly important role in neural precursors (Lilja
et al., 2013; Rudenko and Tsai 2014; Castelo-Branco et al.,
2014). For example, haploinsufficiency forCBP causes cognitive
dysfunction in part because it regulates neural precursor devel-
opment via its histone acetyltransferase (HAT) activity (Wang
et al., 2010). HDAC inhibitors and neural-specific knockouts of
HDACs 1 and 2 also perturb neural precursor proliferation and
differentiation (Lilja et al., 2013), and NCoR, a nuclear coregula-
tor that binds HDACs, is essential for appropriate neural precur-
sor differentiation (Castelo-Branco et al., 2014).
Here, we show that Ankrd11 functions as a nuclear coregula-
tor in the developing brain, regulating histone acetylation and
gene expression, and in so doing determining precursor prolifer-
ation, neurogenesis, and neuronal positioning. Moreover, we
show that when Ankrd11 is decreased or mutated in mice, this
perturbs neural development and when mutated, causes aber-
rant behavior. These findings therefore provide an explanation
for the cognitive dysfunction observed when the ANKRD11
gene is mutated or deleted in humans.lopmental Cell 32, 31–42, January 12, 2015 ª2015 Elsevier Inc. 31
Figure 1. Ankrd11 Is Expressed in Murine
Embryonic Cortical Precursors and Regu-
lates Their Proliferation and Differentiation
in Culture
(A) Quantitative RT-PCR for Ankrd11 mRNA rela-
tive to GAPDH mRNA in the E12 to P3 cortex.
(B) Western blot of Ankrd11 in E11 to P3 cortex.
The blot was reprobed for p130cas as a loading
control.
(C–E) Images of E12 (C) or E16 (D and E) cortical
sections immunostained for Ankrd11 (red) and
Pax6 (D, green) or bIII-tubulin (E, green) and
counterstained with Hoechst 33258 (blue) to
highlight nuclei. The right panels show higher
magnification images of the VZ (C; arrows denote
Ankrd11-positive nuclear foci) or boxed areas
(D and E).
(F) Western blot for Ankrd11 in NIH/3T3 cells
transfected with control (Con) or one of two
Ankrd11 shRNAs (sh1 or sh2). The blot was
reprobed for p130cas.
(G) E12.5 cortical precursors were cultured 3 days
and immunostained for Ankrd11 (red) and Ki67,
Pax6, or bIII-tubulin (all green). Arrows denote
double-positive cells.
(H and I) Precursorswere cotransfectedwith EGFP
and control (Con) or Ankrd11 shRNA (sh1 or sh2)
and immunostained for EGFP (green) and Ankrd11
(red) 2 days later (H), and EGFP-positive cells ex-
pressing detectable Ankrd11 were quantified by
fluorescence intensity (I). (H) shows
cells transfected with Ankrd11 sh2, and the arrow
and arrowhead denote EGFP-positive, Ankrd11-
negative and EGFP-negative, Ankrd11-positive
cells, respectively. **p < 0.01, ***p < 0.005, n = 3
experiments.
(J–P) E12.5 precursors were cotransfected with
nuclear EGFP and control (Con) or Ankrd11 shRNA
(sh1 or sh2) and were analyzed 2 or 3 days later. (J
and K) Cells were immunostained for EGFP (green,
J) and Ki67 (red, J) after 2 days and quantified (K).
Arrow denotes a double-positive cell. **p < 0.01,
n = 4 experiments. (L) EGFP-positive precursors
that were BrdU-positive when cultures were
exposed to BrdU after 1 day and were analyzed
2 days later. **p < 0.01, n = 3 experiments. (M–P)
Cultures were immunostained for EGFP (green, M)
Pax6 or bIII-tubulin (red, M) at 3 days and quantified (N and P) for double-labeled cells (arrows in M). (O) shows the percentage of EGFP-positive, Pax6-positive
cells that were also Ki67-positive, as calculated from (K) and (N). *p < 0.05, **p < 0.01, n = 3 or 4 experiments.
Scale bars represent 100 mm (C), 20 mm (D and E), and 10 mm (G, H, J, M, and Inset in C). Error bars indicate SEM. See also Figure S1.RESULTS
Ankrd11 Is Expressed in Precursors and Neurons of the
Developing Murine Cortex
To ask about Ankrd11 during neural development, we studied
the embryonic cerebral cortex. Quantitative PCR (qPCR) and
western blots (Figures 1A and 1B) showed expression of
Ankrd11 in the embryonic day 11 (E11) through postnatal day 3
(P3) cortex. Immunostaining showed that Ankrd11 was detect-
able in nuclear foci of precursors in the E12 ventricular and sub-
ventricular (VZ/SVZ) zones (Figure 1C). By E16, Ankrd11 was
detectable in nuclei of Pax6-positive radial precursors, the
stem cells in this system, and bIII-tubulin positive neurons in
the cortical plate (Figures 1D and 1E).32 Developmental Cell 32, 31–42, January 12, 2015 ª2015 Elsevier InAnkrd11 Regulates Proliferation and Neurogenesis in
Cultured Murine Cortical Precursor Cells
To identify a potential function for Ankrd11, we generated two
Ankrd11 small hairpin RNAs (shRNAs) and transfected them
into murine NIH/3T3 cells that express endogenous Ankrd11.
Western blots showed that both shRNAs were efficacious and
validated the specificity of the Ankrd11 antibody (Figure 1F).
We used these shRNAs to ask about Ankrd11’s function in
E12.5 radial precursors that generate neurons in culture (Bar-
nabe´-Heider et al., 2005). Ankrd11 immunoreactivity was readily
detectable in nuclei of radial precursors expressing Pax6 and
Ki67 and in newborn bIII-tubulin-positive neurons (Figure 1G).
When cultures were cotransfected with EGFP and Ankrd11
shRNAs, the shRNAs significantly decreased the percentage ofc.
Figure 2. Knockdown of Ankrd11 in
Cultured Murine or Human Cortical Precur-
sors or in the Murine Embryonic Cortex Per-
turbs Proliferation and Neurogenesis
(A–E) E12.5 precursors were cotransfected with
the PB transposase and PB-EGFP reporter, and
control (Con) or Ankrd11 shRNA (sh2), immuno-
stained for EGFP (green, A), Sox2 (red, A), and bIII-
tubulin (purple, A) after 3 days, and quantified for
clones greater than one cell in size (B), neuron-
only clones (C), clones with at least one Sox2-
positive precursor (D), and the number of
Sox2-positive cells in clones with at least one
Sox2-positive precursor (E). Arrows in (A) denote
EGFP-positive, Sox2-positive precursors. *p <
0.05, n = 3 experiments.
(F) ESC-derived human cortical precursors
immunostained for Ankrd11 (red) and Ki67 or bIII-
tubulin (green). Arrows denote double-positive
cells.
(G) Western blot of Ankrd11 in HEK293 cells
transfected with control (Con) or human Ankrd11
shRNA (sh3), analyzed after 24 hr. The blot was
reprobed for p130cas.
(H–K) Human cortical precursors were co-
transfected with EGFP and control (Con) or
human-specific Ankrd11 shRNA (sh3), immuno-
stained 3 days later for EGFP (green, I) and
Ankrd11, Ki67 (red, I), or bIII-tubulin (red, I), and
quantified for EGFP-positive cells expressing
Ankrd11 (H), Ki67 (J), or bIII-tubulin (K). *p < 0.05,
**p < 0.01, n = 3 experiments. Arrows in (I) denote
double-positive cells.
(L–R) E13/14 cortices were electroporated with
EGFP and control (Con) or Ankrd11 shRNA (sh2),
and sections were immunostained 3 days later for
EGFP (green, L and N), Pax6 (red, N), and Ki67
(blue, N) or phospho-histone H3, and quantified for
the relative location of EGFP-positive cells (M) or
the proportions of EGFP-positive, Pax6-positive
cells (O), EGFP-positive, Ki67-positive cells
(P), EGFP-positive, Pax6-positive cells that also
expressed Ki67 (Q), or EGFP-positive, phospho-
histone H3-positive cells (R).
In (L) arrows denote cells in the CP, while (N)
shows confocal images of the VZ/SVZ, with arrows
denoting triple-positive cells and arrowheads
denoting EGFP-positive, Pax6-positive, and Ki67-
negative cells. *p < 0.05, **p < 0.01, ***p < 0.005,
n = 3 embryos each.
Scale bars represent 10 mm (A, F, and I) and 20 mm
(L and N). Error bars indicate SEM. See also
Figure S2.transfected cells expressing Ankrd11 (Figures 1H and 1I).
Ankrd11 knockdown did not affect cell survival, as assessed
by counting EGFP-positive cells with condensed, apoptotic
nuclei (p > 0.05) or by immunostaining for cleaved caspase-3
(Figure S1 available online) 2 days posttransfection. Autophagy
was also unchanged, as monitored by LC3 immunoreactivity
(p > 0.05; data not shown).
Ankrd11 knockdown did affect precursor proliferation, as
measured by Ki67 immunoreactivity 2 days posttransfection or
by adding BrdU to cultures 1 day posttransfection and immuno-
staining for BrdU 2 days later (Figures 1J–1L). This was not due to
a decrease in Pax6-positive radial precursors, but was causedDeveby a decrease in the radial precursor proliferation index (Figures
1M–1O). Ankrd11 knockdown also reduced transfected bIII-
tubulin-positive neurons 3 days posttransfection (Figures 1M
and 1P).
Ankrd11 knockdown also decreased radial precursor self-
renewal, as shown by clonal analysis with the piggybac (PB)
transposon, which indelibly marks precursors and their progeny
(Gallagher et al., 2013). Specifically, precursors were transfected
at low efficiency (Figure S2A) with the PB transposase and PB
EGFP reporter, plus control or Ankrd11 shRNAs, and cultures
were immunostained 3 days later for EGFP, the precursormarker
Sox2, and bIII-tubulin (Figure 2A). Ankrd11 knockdown reducedlopmental Cell 32, 31–42, January 12, 2015 ª2015 Elsevier Inc. 33
EGFP-positive multicellular clones and the proportion of clones
containing a Sox2-positive precursor, while neuron-only clones
were increased (Figures 2B–2D). The number of precursors in
clones containing at least one Sox2-positive cell was also
reduced (Figure 2E).
Ankrd11 Regulates Proliferation and Differentiation of
Human Forebrain Precursors
Since ANKRD11 mutations are associated with human ASD, we
asked whether Ankrd11 was also required for human embryonic
stem cell-derived (ESC-derived) cortical precursors, generated
as we previously described (Wang et al., 2012). Nuclear Ankrd11
immunoreactivity was detectable in almost all cells in these cul-
tures, including Ki67-positive precursors and bIII-tubulin-posi-
tive neurons (Figure 2F). To ask about its function, we generated
a human-targeted Ankrd11 shRNA and confirmed its efficacy
by transfecting it into HEK293 cells that express endogenous
Ankrd11 (Figure 2G). We cotransfected this shRNA into human
neural precursors together with nuclear EGFP. Immunostaining
3 days later showed that the Ankrd11 shRNA significantly
reduced Ankrd11 expression in transfected cells (Figures 2H
and S2B) and that this knockdown decreased EGFP-positive,
Ki67-positive proliferating precursors and EGFP-positive, bIII-
tubulin-positive newborn neurons (Figures 2I–2K), as seen in
murine precursors.
Ankrd11 Knockdown In Vivo Decreases Radial
Precursor Proliferation and Neurogenesis and Causes
Mislocalization of Cortical Neurons
To ask whether Ankrd11 regulates cortical development in vivo
we in utero electroporated E13/14 cortices with nuclear EGFP
and control or Ankrd11 shRNAs and immunostained sections
3 days later. This approach targets radial precursors in the VZ,
many of which differentiate into neurons that migrate through
the intermediate zone (IZ) to the cortical plate (CP). Ankrd11
knockdown altered cell location, with more EGFP-positive cells
in the VZ/SVZ and fewer in the CP (Figures 2L and 2M). Ankrd11
knockdown did not alter EGFP-positive, Pax6-positive radial
precursor numbers, but it did reduce Ki67-positive proliferating
cells and the radial precursor proliferation index (Figures
2N–2Q and S2C). Mitotic cells expressing phospho-histone H3
were also decreased (Figures 2R and S2D).
We immunostained similar sections for the pan-neuronal
marker HuD (Figure 3A). Ankrd11 knockdown decreased EGFP-
positive, HuD-positive neurons by almost 2-fold, and these neu-
rons were misplaced, with fewer in the CP and more in the VZ/
SVZ (Figures 3B and 3C). To define the phenotype of these mis-
placed neurons, we analyzed the layer-specific markers Satb2
and Tbr1 4 days postelectroporation (Figures 3D and 3E). In
controls, Satb2-positive and Tbr1-positive cells comprised about
34%and8%of EGFP-positive cells (Figure 3F), as expected (Tsui
et al., 2013). Following Ankd11 knockdown, Satb2-positive, but
not Tbr1-positive, neurons were reduced (Figure 3F). However,
Tbr1-positive, but not Satb2-positive, neurons were inappropri-
ately positioned at this time point (Figures 3G and S3).
To ask if these neuronal perturbations persisted, we electro-
porated E13/14 cortices with the PB transposase and PB
EGFP reporter, plus control or Ankrd11 shRNA, and analyzed
sections at P3. In controls, almost all EGFP-positive cells were34 Developmental Cell 32, 31–42, January 12, 2015 ª2015 Elsevier Inin layers I to III, but following Ankrd11 knockdown, they were
scattered throughout the cortex, including the SVZ (Figures
3H and 3K). As seen earlier, Ankrd11 knockdown decreased
Satb2-positive, but not Tbr1-positive, neurons, but at this stage
both types of cortical neurons were mislocalized to deeper
cortical layers and the SVZ (Figures 3I–3N).
Yoda Mice Heterozygous for an Ankrd11 Missense
Mutation in the Repressive HDAC-Binding Domain Also
Show Decreased Precursor Proliferation and
Mislocalized Neurons
The Yoda mutant mouse was isolated in an N-ethyl-N-nitro-
sourea screen for perturbations in bone metabolism (Barbaric
et al., 2008) and carries a missense point mutation in the highly
conserved C-terminal repression domain of the Ankrd11 gene
(Figure 4A). Homozygous Yoda mice are embryonic lethal,
but heterozygous mice (Ankrd11Yod/+) survive into adulthood
with altered bone metabolism and craniofacial abnormalities
(Barbaric et al., 2008). Intriguingly, a two amino acid deletion in
the analogous region has been found in the human gene
(Figure 4A) (Sirmaci et al., 2011). To ask if Yoda mice displayed
perturbed neural development, we immunostained E18.5
Ankrd11Yod/+ cortical sections for Tbr1 and Satb2 (Figures 4B
and 4C). Neurons of both phenotypes were misplaced in the
VZ/SVZ of Ankrd11Yod/+ cortices (Figures 4B–4E). In contrast,
the morphology of nestin-positive radial precursors, including
their basal processes, was apparently similar in Ankrd11Yod/+
and wild-type cortices (Figures S4A and S4B).
To extend this analysis, we crossed male Ankrd11Yod/+ mice
with wild-type females, injected pregnant mothers with BrdU at
gestational day 13.5, and immunostained sections 5 days later.
BrdU-positive cells were mislocalized in Yoda cortices (Fig-
ure 4G). We quantified this, using similarly aged wild-type and
Yoda sections triple labeled for Satb2, Pax6, and the intermedi-
ate progenitor marker Tbr2 to define the cortical regions (Figures
4F and S4C). This analysis showed significantly more BrdU-pos-
itive cells in the Ankrd11Yod/+ IZ and fewer in the CP (Figure 4H).
Double labeling also showed significantly fewer BrdU-positive,
Ki67-positive precursors in the VZ/SVZ (Figures 4I and 4K) and
fewer total BrdU-positive, Satb2-positive cells (Figures 4J, 4L,
and S4D) in Ankrd11Yod/+ cortices. These changes were not
due to cell senescence, as monitored by SA-b-gal staining
(data not shown). Thus, as seenwith acuteAnkrd11 knockdowns,
a heterozygous Yodamutation causeddecreased precursor pro-
liferation, and perturbed genesis and localization of neurons.
Ankrd11Yod/+ Mice Have Perturbations in Adult Neural
Precursors and Are Behaviorally Abnormal
We asked whether adult neural precursor cells (NPCs) from
Ankrd11Yod/+ mice were also perturbed, initially focusing on
the adult SVZ. We injected adult wild-type and Ankrd11Yod/+
mice with BrdU and immunostained SVZ sections 24 hr later.
Ankrd11Yod/+ mice had significantly fewer BrdU-positive SVZ
cells and fewer Sox2-positive NPCs that were BrdU-positive
(Figures 5A–5C). We also asked about adult-born olfactory
bulb neurons by immunostaining olfactory bulb sections 1month
following multiple BrdU injections. Adult-born BrdU-positive,
NeuN-positive olfactory bulb neurons were significantly reduced
in Ankrd11Yod/+ mice (Figures 5D and 5E).c.
Figure 3. Ankrd11 Knockdown in Cortical
Precursors Perturbs the Numbers and Posi-
tions of Developing Neurons
(A–G) E13/14 cortices were electroporated with
EGFP and control (Con) or Ankrd11 shRNA (sh1 or
sh2), and sections were immunostained 3 (A–C) or
4 (D–G) days later for EGFP (green) and HuD (red,
A), Satb2 (red, D), or Tbr1 (red, E) and quantified
for the proportions of EGFP-positive cells ex-
pressing HuD (B) or Satb2 and Tbr1 (F) or the
relative location of EGFP-positive, marker-positive
cells (C and G). In (A), (D), and (E), higher magni-
fication images of double-labeled cells (arrows)
are shown at the bottom. *p < 0.05, **p < 0.01, n =
3 embryos each.
(H–N) E13/14 cortices were electroporated with
PB transposase and PB EGFP reporter and con-
trol (Con) or Ankrd11 (sh2) shRNA, and sections
were immunostained at P3 for EGFP (green) and
Satb2 (red, I) or Tbr1 (red, J) and quantified for the
relative location of EGFP-positive, marker-positive
cells in the different cortical layers (K, M, and N) or
the proportions of EGFP-positive cells expressing
Satb2 or Tbr1 (L). In (I) and (J), highermagnification
images of double-labeled cells (arrows) are shown
at the bottom. *p < 0.05, **p < 0.01, ***p < 0.005,
n = 3 each.
Scale bars represent 10 mm (D, lower right panel
and E, lower right panel) and 20 mm (A, D, E, and
H–J). Error bars indicate SEM. See also Figure S3.We also examined the other adult NPC niche, the subgranular
zone (SGZ) of the dentate gyrus, by analyzing hippocampal
sections 24 hr following BrdU injection. The Ankrd11Yod/+ SGZ
contained fewer BrdU-positive cells, Sox2-positive cells, and
double-labeled BrdU-positive, Sox2-positive proliferating NPCs
(Figures 5F–5H and S5A). Doublecortin-positive neuroblasts and
newborn neurons were also reduced in the Ankrd11Yod/+ SGZ
(Figures5I andS5B).Wealso askedaboutmatureadult-bornneu-
rons, administering BrdU and immunostaining hippocampal sec-
tions 1 month later (Figure S5C). BrdU-positive, NeuN-positive
adult-born neurons in the dentate gyrus were significantly
decreased in Ankrd11Yod/+ mice (Figure 5J). Thus, Ankrd11 is
also important for adult NPC proliferation and neurogenesis.
Since ANKRD11 mutations are associated with intellectual
disability and ASD in humans, we characterized the Yoda mice
behaviorally. Initially, we used the open field test to ask aboutDevelopmental Cell 32, 31–4general levels of activity. Ankrd11Yod/+
mice traveled significantly less distance
in the open field than their wild-type
counterparts (Figure 5K). This decrease
was due to a reduction in total time
spent traveling (400.73 ± 25.2 s for
Ankrd11Yod/+ versus 478.9 ± 22.8 for
wild-types, p = 0.03) rather than a change
in movement velocity, which was similar
for both groups (33.7 ± 1.15 cm/s for
Ankrd11Yod/+ and 35.8 ± 1.12 cm/s for
wild-types; p > 0.05).
We then tested the Ankrd11Yod/+ mice
in a three-chamber social preferencetest (Moy et al., 2004) that assays social interactions with an un-
familiar mouse, a behavior that is perturbed in some mouse
models of ASD (Crawley et al., 2007; Molina et al., 2008; Carter
et al., 2011). To perform this test, mice were placed in and al-
lowed to habituate to a three-chamber environment; wild-type
and Ankrd11Yod/+ mice spent equivalent percentages of time in
each of the compartments during this habituation (p > 0.05).
We then put an unfamiliar mouse (stranger 1 [Str1]) in one of
the chambers. As predicted, wild-type mice spent more time in
the chamber side containing the unfamiliar mouse relative to
that containing an inanimate target (Emt) (Figure 5L). In contrast,
Ankrd11Yod/+ mice showed no significant preference (Figure 5L).
Similar results were obtained whether the unfamiliar mouse was
placed in chamber 1 or chamber 3 (p > 0.05).
We then askedwhether themice would prefer a new unfamiliar
mouse over the now-familiar stranger 1 mouse by replacing the2, January 12, 2015 ª2015 Elsevier Inc. 35
Figure 4. Ankrd11Yod/+ Embryos Display
Deficits in Cortical Precursor Prolifera-
tion, Neuronal Numbers, and Neuronal
Localization
(A) Schematic of Ankrd11 showing the Yoda
missense mutation (Barbaric et al., 2008), and a
human deletion in the same region (Sirmaci et al.,
2011).
(B–E) E18.5 Ankrd11Yod/+ (Yoda) and wild-type
(WT) cortical sections were immunostained for
Tbr1 (B) or Satb2 (C), and the relative location of
Tbr1-positive (D) and Satb2-positive (E) neurons
were quantified. Arrows in (B) and (C) denote
misplaced neurons in the VZ/SVZ. *p < 0.05, **p <
0.01, ***p < 0.001, n = 4 each.
(F–L) E18.5 cortical sections from Ankrd11Yod/+
(Yoda) and wild-type (WT) embryos BrdU-labeled
at E13.5 were immunostained for BrdU (red, G, I,
and J) and Ki67 (green, I) or Satb2 (green, J), and
quantified for relative location of BrdU-positive
cells (H), BrdU-positive, Ki67-positive cells in the
VZ/SVZ (K), or total BrdU-positive, Satb2-positive
cells (L). To define the cortical regions in (G) and
(H), E18.5 sections were immunostained for Pax6
(green, F), Satb2 (red, F), and Tbr2 (see Fig-
ure S4C). The IZ/CP border for quantification was
defined by the apical-most edge of the Satb2-
positive neurons in the wild-type sections, as
shown by hatched lines. (I) shows only the VZ/SVZ
and dotted lines indicate the apical edge. Arrows
denote single (G) or double-labeled (I and J) cells.
*p < 0.05, **p < 0.01, n = 4 each.
Scale bars represent 20 mm. Error bars indicate
SEM. See also Figure S4.inanimate object with a second stranger mouse (stranger 2
[Str2]). Wild-type mice spent significantly more time in the cham-
ber containing stranger 2 than in that containing stranger 1.
In contrast, the Ankrd11Yod/+ mice did not prefer the stranger 2
mouse (Figures 5M and 5N).
We then assayed repetitive behaviors, which are thought to be
ASD-like, by measuring self-grooming (Carter et al., 2011). Mice
were placed into a cage for 1 hr to habituate and were then
observed for 10 min. Over this period, Ankrd11Yod/+ mice spent
twice as much time grooming themselves as did their wild-type
littermates (Figure 5O). Thus, Ankrd11Yod/+ mice display behav-
iors that could reflect cognitive dysfunction and ASD-like
perturbations.
Perturbations in Ankrd11 Cause Global Changes in
Gene Expression in Cortical Precursors
To ask if Ankrd11 is a transcriptional coregulator, we compared
gene expression in neural precursors from embryonic Yoda
versus wild-type mice. To do so, we expanded E14 cortical pre-
cursors as neurospheres for 6 days in EGF and FGF2 and then36 Developmental Cell 32, 31–42, January 12, 2015 ª2015 Elsevier Inc.passaged and expanded these as
secondary neurospheres for analysis.
Simultaneously, we grew the same cells
at clonal density for quantification.
The clonal analysis showed that the
Ankrd11Yod/+ embryonic cortex con-tained only about half as many neurosphere-initiating cells
(Figure 6A). Moreover, these were decreased in their ability to
self-renew, since fewer secondary spheres were generated
when they were passaged at clonal density (Figure 6B), confirm-
ing that Ankrd11 is required for cortical precursor self-renewal.
We analyzed the transcriptome of the expanded secondary
neurospheres by microarray, comparing six and five biological
replicates of Ankrd11Yod/+ and wild-type neurospheres,
respectively, with the Affymetrix GeneChip Mouse Gene 2.0
Array (Gene Expression Omnibus (GEO) database accession
number GSE63303). Spearman rank correlation (Figure 6C)
showed that these two populations differed at the tran-
scriptome level. In addition, while the wild-type neuro-
sphere samples were all relatively similar to each other, the
Ankrd11Yod/+ neurospheres showed more heterogeneity,
potentially due to variable penetrance of the heterozygote
phenotype (Figure 6C).
To further investigate these differences, we performed
differential expression analysis to compare the wild-type and
Ankrd11Yod/+ data sets using the Parteks Genomic Suite; 761
Figure 5. Perturbations in Neural Precur-
sors, Adult-Born Neurons, and Behavior in
Adult Ankrd11Yod/+ Mice
(A–J) Adult 6-month-old Ankrd11Yod/+ (Yoda) mice
and their wild-type littermates (WT) were injected
with BrdU, and the SVZ, olfactory bulb (OB), or
dentate gyrus (DG) were analyzed 24 hr (A–C and
F–I) or 30 days (D, E, and J) later. (A–C) Sections
spanning the SVZ 24 hr postinjection were
immunostained for BrdU (green, A) and Sox2
(red, A), and the total BrdU-positive cells (B) and
percentage of Sox2-positive cells that were BrdU-
positive (C) were quantified. Arrows denote dou-
ble-labeled cells. **p < 0.01, ***p < 0.001, n = 3
animals each. (D and E) Sequential olfactory bulb
sections 30 days postinjection were immuno-
stained for BrdU (green, D) and NeuN (red, D), and
the total BrdU-labeled, NeuN-positive neurons
were quantified (E). Arrows show double-labeled
neurons. *p < 0.05, n = 3 each. (F–I) Quantification
of sections 24 hr post-BrdU injection for total
subgranular zone (SGZ) cells that were BrdU-
positive (F), Sox2-positive (G), BrdU- and Sox2-
positive (H) or doublecortin-positive (I). ***p <
0.001, n = 3 each. (J) Quantification 30 days
postinjection for total BrdU-positive, NeuN-posi-
tive dentate gyrus neurons. ***p < 0.001, n = 3
each.
(K–O) Adult Ankrd11Yod/+ (Yoda) and wild-type
(WT) littermates were analyzed behaviorally. (K)
Total distance traveled (centimeters) in the open
field test. *p < 0.05, n = 15 WT and 9 Ankrd11Yod/+
mice. (L and M) Percentage of time spent in the
stranger 1 (Str1) chamber versus the empty
container (Emt) chamber (L) and in the stranger 1
(Str1) chamber versus the new stranger 2 (Str2)
chamber (M) during the three-chamber sociability
test. *p < 0.05, **p < 0.01, two-way repeated-
measures ANOVA (genotype X side) with
Bonferroni’s post hoc analysis, n = 15 WT and
9 Ankrd11Yod/+ mice, ns = not significant. (N)
Social novelty index, calculated as [timeStr2/(timeStr2 + timeStr1)] 3 100  50 (Jamain et al., 2008). *p < 0.05, n = 15 WT and 9 Ankrd11Yod/+ mice. (O) Total
time spent self-grooming (seconds) over a 10 min test period. **p < 0.01, n = 15 WT and 7 Ankrd11Yod/+ mice.
Scale bars represent 100 mm (A and D). Error bars indicate SEM. See also Figure S5.genes, or approximately 3% of those analyzed, were signifi-
cantly differentially expressed (using false discovery [FDR]
p value < 0.1 and fold change [FC] > 1.1 or < 1.1) (Figure 6D
and Table S1). These genes clearly distinguished the
Ankrd11Yod/+ and wild-type precursors, as shown in a heatmap
(Figure 6E). We validated these results by real-time qPCR,
confirming mRNAs that were upregulated (Notch1, Slc1A2,
Mll5, Fzd3, Sox6, Ncor1, Foxn3, Med13, and Ncoa1) or down-
regulated (Eya2, Med10, Foxp1, and Gabrg1) in Ankrd11Yod/+
neurospheres. This analysis validated the microarray data (Fig-
ure 6F), showing a Pearson correlation coefficient of 0.995
(Figure 6G).
We then subjected the 761 differentially expressed genes to
gene ontology and pathway analysis. This analysis showed
that the enriched pathways were diverse in terms of their func-
tions (Figure 6H and Table S2). Intriguingly, two disorder cate-
gories with the highest p values were schizophrenia and
abnormal morphology of the nervous system (Figure 6H), consis-
tent with the phenotypes that we observed in the Yoda mice.DeveAnkrd11 Associates with Chromatin, and Histone
Acetylation Is Increased, in Ankrd11Yod/+ Neural
Precursors
Since Ankrd11 can bind HDACs, we asked whether chromatin
acetylation was altered in Yoda mice, initially isolating total his-
tones from adult Ankrd11Yod/+ and wild-type cortices. Western
blots demonstrated increased acetylation of histones H3 and
H4 at H3K9, H4K5, H4K8, and H4K16 (Figure 7A), all known
HDAC3 target sites (Rudenko and Tsai, 2014). We then exam-
ined histone acetylation in the E14 cortical neurospheres used
for the microarrays. Western blots showed that, relative to total
histone H4, acetylation in the Ankrd11Yod/+ neurosphere chro-
matin was increased at H4K5, H4K8, H4K16, and H3K9, but un-
altered at H3K14 and H3K27 (Figures 7B and 7C).
To ask if altered histone acetylation could explain the
observed gene expression changes, we analyzed H4K16
acetylation on genes upregulated in Ankrd11Yod/+ neurospheres,
focusing on Notch1, Slc1A2, Mll5, Fzd3, Sox6, and Ncor1. To
do so, we immunoprecipitated cortical neurosphere chromatinlopmental Cell 32, 31–42, January 12, 2015 ª2015 Elsevier Inc. 37
Figure 6. Alterations in Self-Renewal and
Gene Expression in Embryonic Cortical
Precursors from Ankrd11Yod/+ Mice
Analysis of Ankrd11Yod/+ (Yoda) and wild-type
(WT) E14 cortical neurospheres.
(A and B) Number of primary (A) and secondary (B)
neurospheres generated from E14 cortical cells at
clonal density **p < 0.01, ***p < 0.005, n = 6 WT
and 7 Ankrd11Yod/+ embryos.
(C–E) Microarray analysis of six and five indepen-
dent isolates of Ankrd11Yod/+ and wild-type
secondary cortical neurospheres (Yoda1-6 and
WT1-5). (C) Spearman rank correlation matrix
computed for the microarray experiments based
upon all 41,345 probe sets, with red and blue
representing the most and least highly correlated
samples, respectively. (D) Venn diagram of a
pair-wise comparison showing genes that were
significantly different (using FDR p value < 0.1 and
FC > 1.1 or <1.1). (E) A heatmap of the 761 genes
that were significantly differentially expressed in
(D), clustered using Partek Genomics Suite. The
genes are shown in Table S1.
(F) qRT-PCR analysis of genes selected from the
microarray analysis. *p < 0.05, **p < 0.01, n =
mRNA from six secondary neurosphere samples
each.
(G) Correlation of fold change in gene expression
(Ankrd11Yod/+ versus WT neurospheres) for the
microarrays versus the qRT-PCRs. Each point
represents the average value of genes in (F) from
at least 6 mRNA preparations each. Pearson’s
correlation coefficient R2 = 0.995, p = 0.00003.
(H) Significantly differentially expressed genes
from (E) were analyzed using Ingenuity pathway
analysis, and the top pathways are presented.
Categories are color-coded based on the number
of genes they contain. Genes in each category are
shown in Table S2. See also Tables S1 and S2.with anti-H4K16ac or anti-H4 and analyzed genomic elements
located within 1 kb of the 50 untranslated region by qPCR,
focusing on sequences associated with acetylated H3K27 in
E14.5 whole brain (ENCODE database, GEO accession number
GSM1000094) (Rosenbloom et al., 2013). This analysis showed
that, in Ankrd11Yod/+ neurospheres, H4K16 acetylation was
significantly increased on the Notch1, Slc1A2, Mll5, Fzd3, and
Sox6 genomic elements (Figure 7D).
To ask if these genomic loci were direct targets of Ankrd11, we
performed chromatin immunoprecipitation (ChIP) with anti-
Ankrd11. Since the p21 gene is directly regulated by Ankrd11
(Neilsen et al., 2008), we initially validated the Ankrd11 antibody
for ChIP with the p21 promoter (Neilsen et al., 2008). This anal-
ysis showed that anti-Ankrd11 immunoprecipitates were signifi-
cantly enriched for the p21 gene element relative to nonspecific
IgG and to the desert region on chromosome 15, which is at least
500 kbp away from any known gene (Figure S6A). We then per-
formed ChIP for the selected genes in wild-type neurospheres.38 Developmental Cell 32, 31–42, January 12, 2015 ª2015 Elsevier Inc.Ankrd11 was significantly associated
with Notch1, Slc1A2, Mll5, Fzd3, Sox6,
and Ncor1 gene elements, but not with
Foxn3, Med10, or Ncoa1 gene elements(Figure 7E). Importantly, none of these latter gene elements
showed significantly altered H4K16 acetylation in Ankrd11Yod/+
neurospheres (p > 0.06; data not shown).
Ankrd11 Controls Neural Precursor Proliferation via
HDAC3 and Histone Acetylation
The strong correspondence between Ankrd11 chromatin asso-
ciation sites and increased H4K16 acetylation at those sites
in Ankrd11Yod/+ neurospheres suggests that Ankrd11 directly
regulates HDAC function. To test this idea, we focused on
HDAC3, which interacts with Ankrd11 when overexpressed
(Zhang et al., 2004). Immunostaining of cultured precursors
showed that HDAC3 was present in some Ankrd11-positive
nuclear foci (Figure 7F). To ask if they directly associated, we
performed proximity ligation assays, which provide a positive
readout when antibody targets are within 40 nm of each other
(So¨derberg et al., 2006). Bright fluorescent nuclear puncta
were observed when anti-Ankrd11 and anti-HDAC3 were
Figure 7. Ankrd11 Associates with Chro-
matin, Histone Acetylation Is Increased in
Ankrd11Yod/+ Neural Precursors, and This
Causes Decreased Precursor Proliferation
(A–C) Western blots with acetylation-site specific
histone antibodies (H4K5ac, H4K8ac, H3K9ac,
H4K16ac, H3K14ac, H3K27ac) in total histones
isolated from adult Ankrd11Yod/+ (Yoda) and wild-
type (WT) cortices (A) or in chromatin protein from
E14 cortical secondary neurospheres (B). Sam-
ples were also probed for total histone H4, and (C)
shows chemiluminescence quantification relative
to H4 of blots as in (B). *p < 0.05, n = 7 neurosphere
samples each.
(D) ChIP-qPCR of E14 cortical neurosphere
chromatin immunoprecipitated with anti-H4K16ac
or anti-H4. Genomic loci associated with anti-
H4K16ac or anti-H4 were expressed as percent
input, and H4K16ac values were normalized to
total H4 values. *p < 0.05, **p < 0.01, n = 5
neurosphere samples each.
(E) ChIP-qPCR of wild-type E14 neurosphere
chromatin immunoprecipitatedwithanti-Ankrd11or
nonspecific IgG (dashed line). Genomic loci asso-
ciated with anti-Ankrd11 or IgG were expressed as
percent input and normalized to IgG (equated to 1).
Blue and gray bars designate loci that were signifi-
cantly (*p < 0.05, **p < 0.01) or not significantly
associated (N.S.) with Ankrd11, respectively. n = 4
E14 cortical neurosphere samples.
(F) Confocal images of E12.5 cultured cortical
precursor nuclei immunostained for Ankrd11
(green) and HDAC3 (red). The boxed areas are
also shown at higher magnification on the bottom.
Arrows denote colocalization.
(G) Cortical precursor nuclei (blue, Hoechst)
following the proximity ligation assay with anti-
HDAC3andanti-Ankrd11 (right, red puncta) or, as a
negative control, anti-eIF4E and anti-Ankrd11 (left).
(H and I) E12.5 precursors were cotransfected
with EGFP and control (Con) or Ankrd11 (sh2)
shRNA. Cells were treated with 500 nM C646
HAT inhibitor after 2 days (H), or they were co-
transfected with a control or HDAC3 expression
vector (I). Three days posttransfection, cells were
immunostained for EGFP and Ki67 and quantified.
**p < 0.01, ***p < 0.001, analyzed by ANOVA with
Fisher’s post hoc test. n = 3 experiments each.
Scale bars represent 5 mm (F) and 10 mm (G). Error
bars indicate SEM. See also Figure S6.combined, but not when anti-eIF4E, which robustly immunos-
tains cortical precursors (Yang et al., 2014), was combined
with either anti-Ankrd11 or anti-HDAC3 (Figures 7G and S6B).
These data identify an Ankrd11/HDAC3 complex in cortical
precursors and suggest that Ankrd11 mutation or knockdown
disrupts this complex and thus abnormally elevates histone
acetylation. We therefore asked whether rebalancing histone
acetylation with the HAT inhibitor C646 (Bowers et al., 2010)
would rescue the Ankrd11 knockdown-induced changes,
focusing on precursor proliferation. Cultured precursors were
transfected with EGFP and control or Ankrd11 shRNA, were
treated with 500 nM C646 after 1 day, and were stained for
Ki67 2 days later. C646 completely rescued the reduced prolifer-
ation seen following Ankrd11 knockdown (Figure 7H).DeveFinally, we asked whether ectopic HDAC3 expression could
also rescue this proliferation phenotype. Cultured precursors
were cotransfected with EGFP and Ankrd11 shRNA with
or without an HDAC3 expression plasmid. Immunostaining
3 days later demonstrated that HDAC3 had no effect on Ki67-
positive cells under basal conditions but completely rescued
the decreased proliferation caused by Ankrd11 knockdown
(Figure 7I).
DISCUSSION
ASD is a constellation of behaviorally related neurodevelopmen-
tal disorders with a strong genetic component. Many genes have
been associated with ASD, and one key question is how theylopmental Cell 32, 31–42, January 12, 2015 ª2015 Elsevier Inc. 39
cause ASD-type behaviors. In this regard, a subset of these
genes regulates synaptogenesis, but a further subset has no
identified function in the brain. Here, we have focused upon
one of the latter genes encoding a nuclear protein, Ankrd11,
which has been implicated as a transcriptional coregulator. Indi-
viduals with ANKRD11 mutations display neurodevelopmental
phenotypes, including aspects of ASD, cognitive disability (Sir-
maci et al., 2011; Lo-Castro et al., 2013; Iossifov et al., 2014),
and neuroanatomical perturbations such as periventricular het-
erotopias (Willemsen et al., 2010) Here, we show that Ankrd11
plays an important role during neural development, acting to
determine appropriate histone acetylation and gene expression
and thus proliferation of embryonic neural precursors and the
genesis and positioning of newborn neurons. Moreover, we
show that disruption of Ankrd11 causes long-lasting changes
in the adult forebrain together with ASD-like behaviors, thereby
providing an explanation for the perturbations that occur when
ANKRD11 is mutated in humans.
Howdoes Ankrd11 regulate neural development?We propose
it functions as a transcriptional coregulator that binds to HDAC3
and potentially other HDACs, and in so doing regulates histone
acetylation, gene expression, and ultimately the biology of devel-
oping precursors and neurons. This model is based upon previ-
ous work in cell lines together with data here showing that (1)
HDAC3 and Ankrd11 colocalized and associated in cortical pre-
cursors, (2) histone acetylation was increased and gene expres-
sion broadly perturbed in Yoda cortical precursors, (3) for some
genes, this increased histone acetylation and gene expression
correlatedwith Ankrd11 chromatin association, and (4) rebalanc-
ing histone acetylation by overexpression of HDAC3 or pharma-
cological HAT inhibition rescued the Ankrd11 knockdown-medi-
ated decrease in precursor proliferation. Thismodel is consistent
with previous studies showing that disruption of HDAC3 altered
neural precursor proliferation and neuronal differentiation (Sun
et al., 2007; Castelo-Branco et al., 2014) and caused increased
H4K8 acetylation coincident with changes in neuronal gene
expression (McQuown et al., 2011), phenotypes that are reminis-
cent of those seen following disruption of Ankrd11.
A number of additional intriguing conclusions came from the
Yoda cortical precursor gene expression analyses. First, the
type of genes that were deregulated in Yoda precursors was
diverse, suggesting that Ankrd11 likely plays a relatively global
role as a transcriptional coregulator. Many of these deregulated
genes encode known regulators of cortical development,
including transcriptional or chromatin regulators such as SOX6,
RelA, RB1, Notch1, NCOA1, NCOR1, NCOR2, MLL5, ARID2,
MED10, MED13, WDR61, WDR26, FOXP1, ZEB2, ATF5, EYA2,
and FOXN3 and signaling molecules such as PTCH1, DCC,
SEMA5B, FZD3, and, SPRY1 (see Table S1). Our ChIP studies
indicate that at least a subset of these genes are directly associ-
ated with Ankrd11. Thus, Ankrd11 may coordinately regulate
multiple genes important for neural development by modulating
or fine-tuning their expression. Second, one robust disease as-
sociation for the deregulated genes was schizophrenia. Since
many genes implicated in ASD are also associated with schizo-
phrenia (Mullin et al., 2013; McCarthy et al., 2014), then our
finding that mutation of an ASD-associated gene caused
changes in genes implicated in schizophrenia supports the
idea of a common cellular network.40 Developmental Cell 32, 31–42, January 12, 2015 ª2015 Elsevier InOur data show that Yoda mice, like humans carrying one
mutant ANKRD11 allele, exhibit neuroanatomical perturbations
such as neurons misplaced around the lateral ventricles (peri-
venticular heterotopias) and ASD-like behaviors. These findings
are intriguing in light of the recent description of patches of
cortical disorganization in children with autism (Stoner et al.,
2014) and support the idea that the Yoda mouse is a model for
the human situation. However, these findings also raise the
possibility that there are multiple mechanisms that can lead to
ASD-like behavior, both in mice and humans. While one likely
mechanism involves later aspects of circuit formation like synap-
togenesis, our findings suggest a second important mechanism
involving early changes in neurogenesis and neuronal specifica-
tion and/or localization that ultimately provide an aberrant tem-
plate upon which to build the circuitry that is essential for normal
cognitive function.
EXPERIMENTAL PROCEDURES
Animals and Genotyping
All animal use was approved by the Hospital for Sick Children Animal Care
Committee in accordance with Canadian Council of Animal Care policies.
Ankrd11Yod/+ mice (Barbaric et al., 2008) were from the European Mouse
Mutant Archive and genotyped as in Supplemental Experimental Procedures.
CD1 mice (Charles River) were used in all other experiments.
Plasmids and shRNAs
We used previously published plasmids, pEF-EGFP, PCAG-PB-EGFP,
and PCAG-Pbase (Gallagher et al., 2013). The HDAC3 plasmid (Origene)
was in the pCMV6 backbone and Ankrd11 shRNAs (EZ Biolabs) were in
the pGCsi backbone. shRNA sequences are in Supplemental Experimental
Procedures.
Cell Cultures
E12.5 cortical precursors were cultured and transfected at 125,000–150,000
cells/ml as described (Barnabe´-Heider et al., 2005). E14 cortical neurospheres
were cultured and passaged at 6 days under standard conditions at 50 cells/ml
for biochemistry and clonal density (Coles-Takabe et al., 2008) for quantifica-
tion, counting spheres with at least 10 cells. For human precursors, Hes2 ESCs
were differentiated as described (Wang et al., 2012). HEK293 cells and NIH/
3T3 cells were cultured as described (Zander et al., 2014). Additional details
are in Supplemental Experimental Procedures.
In Utero Electroporations and BrdU Experiments
In utero electroporations and embryonic BrdU experiments were performed
as described (Zander et al., 2014). For adult BrdU studies, 6-month-old mice
were injected once with 100 mg/Kg BrdU or five times with 60 mg/kg
BrdU and analyzed 24 hr or 30 days later, respectively, by counting 10 SVZ,
dentate gyrus or olfactory bulb sections, sampled every tenth section, as
described (Cancino et al., 2013) and detailed in Supplemental Experimental
Procedures.
Immunocytochemistry, Proximity Ligation Assays, Microscopy, and
Quantification
Immunocytochemistry of cultured cells and cryopreserved or paraffin-
embedded tissue was performed as described (Cancino et al., 2013; Zander
et al., 2014). Proximity ligation assays were carried out using Duolink in situ
red starter kit for mouse/rabbit as per manufacturer’s instructions (Olink
Bioscience). For culture knockdowns or for clonal analysis, over 100 trans-
fected cells or clones per condition per experiment were quantified. For
Ankrd11 expression levels, Northern Eclipse (Empix) software was used to
determine signal over a threshold level. For in vivo analysis, coronal sections
were analyzed using a Zeiss Pascal confocal microscope. Four sections per
embryo were analyzed, taking three pictures covering the VZ, SVZ, IZ, and
CP of sections at equivalent anatomic levels.c.
qRT-PCR and Microarrays
RNA and cDNA preparation, primers and qRT-PCR methods are in Supple-
mental Experimental Procedures. For microarrays, 5.5 mg of cDNAwas hybrid-
ized to the Affymetrix Gene Chip Mouse Gene 2.0 ST and results analyzed
using Partek Genomics Suite 6.6. Only probesets for annotated genes were
used for differential expression analysis. ANOVA statistics were calculated
and the genes with FDR p value < 0.1 and FC > 1.1 or <1.1 were considered
statistically significant. Affymetrix Expression Console 1.1 was used for
Spearman rank correlations, Partek Genomics Suite 6.6 for unbiased hierar-
chical clustering and heatmaps, and Ingenuity Pathway Analysis (IPA, version
18488943) for gene ontology pathways. Microarray data can be found at GEO
accession number GSE63303.
Chromatin Preparations and Immunoprecipitation Analysis
Chromatin from secondary passage neurospheres was prepared as described
(Savage et al., 2009; Supplemental Experimental Procedures). ChIP was
performed as described (Savage et al., 2009) with 20 mg chromatin and 4 mg
anti-Ankrd11 (Neilsen et al., 2008) or nonspecific rabbit IgG (Millipore), or
2 mg chromatin and 2 mg anti-H4 or anti-H4K16ac (Millipore). Chromatin was
reverse crosslinked, DNA purified, and Ankrd11-, H4K16ac-, and total H4-
bound chromatin calculated as percent input by qPCR with primers listed in
Supplemental Experimental Procedures. To be considered a true association,
enrichment with a specific antibody was compared to nonspecific IgG
(p < 0.05). All primers were validated and qPCR assays were performed in
accordance with Minimum Information for Publication of Quantitative Real-
Time PCR Experiments guidelines.
Western Blots and Densitometry
Westerns for proteins other than histones were performed as described (Bar-
nabe´-Heider et al., 2005). For cortical histones, tissue was dissected in PBS
plus 5 mM sodium butyrate to retain acetylation, and histones were extracted
and analyzed as described in Supplemental Experimental Procedures. For
neurospheres, 1 mg chromatin was reverse-crosslinked at 65C for 16 hr, incu-
bated at 95C in Laemmli sample buffer for 10 min, and analyzed on western
blots. Images were captured using MicroChemi4.2 imaging system (DNR
Bio-imaging Systems), and densitometry performed using GelQuant software
(DNR Bio-imaging Systems). Background was subtracted using the rolling ball
method, and densities were normalized to total H4 and expressed over one of
the wild-type samples (equated to ‘‘1’’). Antibodies are in Supplemental Exper-
imental Procedures.
Behavioral Analyses
Mice were tested at 10 weeks of age, and their behavior was assessed as in
Supplemental Experimental Procedures.
Statistics
All data other than the microarray were expressed as mean ± SEM and tested
for significancewith Student’s t tests unless otherwise indicated, in which case
they were analyzed with an ANOVA with Fisher’s post hoc test or by two-way
repeated-measures ANOVA (genotype X side) with Bonferroni’s post hoc test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.devcel.2014.11.031.
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